IN BRIEF: Open Orphan denies any involvement in insider trading claim

Open Orphan PLC - London-based research organisation testing infectious and respiratory disease ...

Alliance News 15 September, 2022 | 12:02PM
Email Form Facebook Twitter LinkedIn RSS

Open Orphan PLC - London-based research organisation testing infectious and respiratory disease products - Confirms that it is helping the relevant Irish authorities with an allegation of potential insider trading dealing in the company's shares in 2020. Open Orphan says trading in the company's shares was undertaken by an "unconnected private individual". It said "there are no implications for the company in the resolution of this allegation and confirms that no employee, executive, director or anyone connected with the company had any involvement whatsoever in this matter nor are they suspected of any wrongdoing."

Current stock price: 9.67 pence, up 9.8%

12-month change: down 61%

By Chris Dorrell; chrisdorrell@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Open Orphan PLC 9.80 GBX 4.70 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures